Summit Financial LLC acquired a new position in shares of Nutrien Ltd. (NYSE:NTR - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 92,511 shares of the company's stock, valued at approximately $4,189,000.
Several other hedge funds and other institutional investors have also made changes to their positions in NTR. Uncommon Cents Investing LLC grew its position in Nutrien by 2.1% in the 4th quarter. Uncommon Cents Investing LLC now owns 11,550 shares of the company's stock valued at $517,000 after buying an additional 235 shares in the last quarter. Rhumbline Advisers increased its stake in shares of Nutrien by 3.5% during the fourth quarter. Rhumbline Advisers now owns 7,398 shares of the company's stock valued at $331,000 after acquiring an additional 247 shares during the period. FFT Wealth Management LLC raised its holdings in Nutrien by 0.9% during the fourth quarter. FFT Wealth Management LLC now owns 29,732 shares of the company's stock worth $1,330,000 after purchasing an additional 277 shares in the last quarter. EverSource Wealth Advisors LLC lifted its position in Nutrien by 23.9% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,804 shares of the company's stock worth $81,000 after purchasing an additional 348 shares during the period. Finally, Daiwa Securities Group Inc. boosted its stake in Nutrien by 20.8% during the 3rd quarter. Daiwa Securities Group Inc. now owns 2,213 shares of the company's stock valued at $106,000 after purchasing an additional 381 shares in the last quarter. 63.10% of the stock is currently owned by institutional investors and hedge funds.
Nutrien Stock Down 6.4 %
Nutrien stock traded down $3.27 during trading hours on Friday, hitting $47.44. The company had a trading volume of 5,469,154 shares, compared to its average volume of 2,036,364. Nutrien Ltd. has a fifty-two week low of $43.70 and a fifty-two week high of $60.87. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.27 and a quick ratio of 0.82. The firm has a market capitalization of $23.19 billion, a P/E ratio of 34.63, a price-to-earnings-growth ratio of 1.19 and a beta of 0.77. The firm's fifty day moving average is $51.30 and its 200-day moving average is $49.10.
Nutrien (NYSE:NTR - Get Free Report) last posted its quarterly earnings results on Wednesday, February 19th. The company reported $0.28 earnings per share for the quarter, missing analysts' consensus estimates of $0.37 by ($0.09). The company had revenue of $5.08 billion during the quarter, compared to analyst estimates of $5.09 billion. Nutrien had a return on equity of 6.81% and a net margin of 2.62%. On average, research analysts forecast that Nutrien Ltd. will post 3.72 earnings per share for the current year.
Nutrien Cuts Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, April 10th. Investors of record on Monday, March 31st will be issued a $0.545 dividend. The ex-dividend date is Monday, March 31st. This represents a $2.18 dividend on an annualized basis and a yield of 4.60%. Nutrien's dividend payout ratio is currently 159.12%.
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on the company. JPMorgan Chase & Co. upgraded Nutrien from an "underweight" rating to a "neutral" rating and upped their price objective for the company from $40.00 to $50.00 in a report on Monday, January 13th. Barclays upped their price target on shares of Nutrien from $56.00 to $59.00 and gave the company an "equal weight" rating in a report on Wednesday, March 5th. Royal Bank of Canada restated an "outperform" rating and set a $60.00 price objective on shares of Nutrien in a research report on Monday, February 24th. Oppenheimer began coverage on shares of Nutrien in a research note on Thursday, December 12th. They set an "outperform" rating and a $60.00 target price for the company. Finally, UBS Group lifted their price target on shares of Nutrien from $53.00 to $54.00 and gave the stock a "neutral" rating in a research report on Thursday, February 20th. Two analysts have rated the stock with a sell rating, five have given a hold rating and eight have assigned a buy rating to the company. According to MarketBeat, Nutrien has a consensus rating of "Hold" and an average target price of $60.00.
Get Our Latest Analysis on Nutrien
About Nutrien
(
Free Report)
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Read More
Before you consider Nutrien, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nutrien wasn't on the list.
While Nutrien currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
